← Open Payments lookup

MAKENZIE SCHEMBARI: Open Payments

NPI 1124742424 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$768 in 25 payments from 10 companies in 2025. Trend: 2023 $2,067 · 2024 $1,683 · 2025 $768

Food & beverage: $768
CompanyPaymentsAmount
ABBVIE INC.8$244
AstraZeneca Pharmaceuticals LP3$159
Janssen Biotech, Inc.1$112
PFIZER INC.3$55
Bayer Healthcare Pharmaceuticals Inc.2$53
Novo Nordisk Inc3$53
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$37
Takeda Pharmaceuticals U.S.A., Inc.1$22
Boston Scientific Corporation1$19
Axsome Therapeutics, Inc.1$14

Products named: VRAYLAR, LYNPARZA, RYBREVANT, ELAHERE, PREVNAR 20, Kerendia, CAPLYTA, Ozempic.

Industry payments across IN — which companies pay providers there.